Obstetrics & Gynecology Doctors in Siloam Springs, AR Accepting Medicare

3 Obstetrics & Gynecology doctors found. Showing 1 - 3

Dr. Mary Kathleen Marquette, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 603-2 N Progress Ave Ste 100, Siloam Springs, AR 72761 Phone: 479-524-9312    Fax: 479-524-9627

Dr. Natalie Zoe Eiland, D.O. Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 603-2 N Progress Ave Ste 100, Siloam Springs, AR 72761 Phone: 479-524-9312    Fax: 479-524-9627

Dr. Chad Hill, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 603-2 N Progress Ave, Suite 100, Siloam Springs, AR 72761 Phone: 479-524-9312    Fax: 479-524-9627

News Archive

Treatment at earliest age reduces symptoms of autism spectrum disorder

Treatment at the earliest age when symptoms of autism spectrum disorder (ASD) appear - sometimes in infants as young as 6 months old - significantly reduces symptoms so that, by age 3, most who received the therapy had neither ASD nor developmental delay, a UC Davis MIND Institute research study has found.

Biobanks should set rules for overall process of recognizing IFs and IRRs

Bioethicists at the Johns Hopkins Berman Institute of Bioethics are co-authors on a consensus article placing "significant responsibility" on biobanks to report individual research results (IRRs) and incidental findings (IFs) to the contributors of genetic material.

Ralphs Pharmacies continue to offer Tdap vaccinations for whooping cough in Southern California

As the number of pertussis cases, also known as whooping cough, reaches epidemic proportions in California, Ralphs Pharmacies continue to offer Tdap (tetanus, diphtheria, pertussis) vaccinations at its 85 in-store pharmacies throughout Southern California.

VBI Vaccines completes acquisition of Epixis

VBI Vaccines (VBI), a biotechnology company dedicated to the innovative formulation, development and delivery of safe and effective vaccines, announced today that it has completed the acquisition of Epixis S.A., a French biotechnology company developing its "eVLP" platform technology for a new generation of Virus-Like Particle (VLP) vaccines.

Dr. Reddy's launches OTC Lansoprazole delayed-release capsules in the U.S.

Dr. Reddy's Laboratories announced today that it has launched over-the-counter (OTC) Lansoprazole delayed-release capsules in the U.S. market on May 18, 2012, following Dr. Reddy's ANDA approval by the United States Food & Drug Administration.

Read more Medical News

› Verified 1 days ago